Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2024-03-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于控股子公司获得药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining a drug registration certificate from the national drug regulatory authority. It details the drug name, registration information, and potential impact on the company. There is no financial data, no mention of financial results, no report attached or referenced, and no regulatory filing or certification. The document is an official announcement about a business development related to product registration, which does not fit into financial reports or management changes. It is a regulatory announcement about a material event affecting the company, best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2024-03-11 Chinese
关于控股子公司及其下属子公司开展应收账款无追索权保理业务的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Chongqing Pharmaceutical Holdings Co., Ltd. regarding its controlling subsidiary and its subsidiaries conducting non-recourse factoring business on accounts receivable. It includes details about the transaction overview, previous business progress, the 2024 transaction plan, and the impact on the company. The document references board resolutions and shareholder meeting approvals but does not contain financial statements or detailed financial analysis. The length is short (973 characters), and it is clearly an announcement of a financing-related transaction rather than a full financial report. Therefore, it fits best under Capital/Financing Update (CAP).
2024-03-08 Chinese
第九届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fourth meeting of the ninth board of directors of the company. It details the meeting date, attendance, and the voting results on various financing plans, guarantees, issuance of debt products, and governance policies. The document repeatedly references that the specific content of each resolution is disclosed in separate announcements. The document does not contain detailed financial statements or comprehensive financial analysis but rather the outcomes of board decisions. This type of document is a Board/Management Information announcement, as it reports on board meeting resolutions and management decisions rather than full financial reports or shareholder meeting materials.
2024-03-08 Chinese
《总法律顾问制度》
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '总法律顾问制度' (General Legal Counsel System) for 重药控股股份有限公司, outlining the appointment, responsibilities, qualifications, and accountability of the company's General Legal Counsel. It is a governance-related document focusing on internal rules, management roles, and compliance procedures rather than financial results, legal proceedings, or shareholder communications. It does not contain financial data, audit information, or regulatory filings. It is not an announcement or a report publication notice but a governance framework document. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3753 characters, which is sufficient for a substantive governance policy document.
2024-03-08 Chinese
关于为控股子公司申请银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the provision of guarantees by the parent company for bank credit applications of its controlling subsidiaries. It includes extensive financial data such as asset-liability ratios, guarantee amounts, and shareholder information for multiple subsidiaries. The document references a board meeting resolution and the need for shareholder approval, indicating it is a formal corporate announcement. There is no indication that this is a full financial report like an annual or interim report, nor is it a transcript, audit report, or legal proceeding. The content focuses on financing-related guarantees and credit support arrangements, which aligns with updates on financing activities or capital structure changes. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed financial figures, supporting a high confidence in classification.
2024-03-08 Chinese
《合规管理制度》
Governance Information Classification · 95% confidence The document is titled '合规管理制度' which translates to 'Compliance Management System'. It is a detailed internal policy document outlining the company's compliance management framework, responsibilities, principles, and procedures. It includes chapters on general provisions, compliance management responsibilities, key compliance areas, operation, and guarantees. There is no indication that this is a financial report, audit report, earnings release, or any other financial filing. It is not an announcement or a brief summary but a comprehensive governance-related document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-03-08 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.